An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts

Cancer is a heterogeneous disease caused by diverse genomic alterations in oncogenes and tumor suppressor genes. Despite recent advances in high-throughput sequencing technologies and development of targeted therapies, novel cancer drug development is limited due to the high attrition rate from clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Sung-Yup, Kang, Wonyoung, Han, Jee Yun, Min, Seoyeon, Kang, Jinjoo, Lee, Ahra, Kwon, Jee Young, Lee, Charles, Park, Hansoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Molecular and Cellular Biology 2016
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757806/
https://www.ncbi.nlm.nih.gov/pubmed/26831452
http://dx.doi.org/10.14348/molcells.2016.2350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757806/
https://www.ncbi.nlm.nih.gov/pubmed/26831452
http://dx.doi.org/10.14348/molcells.2016.2350

Ejemplares similares